Advertisement

Coronary intravascular brachytherapy for in-stent restenosis: A review of the contemporary literature

      Abstract

      Intracoronary stent restenosis (ISR) is a clinically relevant challenge in the modern era. Heterogeneity in patient- and lesion-specific factors can further compound this clinical challenge. Coronary intravascular brachytherapy (IVBT) was the standard therapeutic approach for ISR prior to the advent of drug-eluting stents (DES). Despite prospective data describing the superiority of DES over IVBT for treating de novo ISR, IVBT remains a treatment option for patients with complex disease. The purpose of this review is to evaluate the historical and contemporary literature surrounding IVBT in order to elucidate its role in modern cardiac care and to describe opportunities for future investigations to improve patient selection. Herein, we provide a review of the contemporary literature describing IVBT as a safe and effective treatment option for patients with recurrent, refractory ISR after multilayer DES and no good surgical or mechanical option. Combination therapy with emerging technologies such as DCBs may further increase efficacy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Virani S.S.
        • Alonso A.
        • Aparicio H.J.
        • et al.
        Heart disease and stroke statistics-2021 update: a report from the American Heart Association.
        Circulation. 2021; 143: e254-e743
        • Almarzooq Z.I.
        • Wadhera R.K.
        • Xu J.
        • Yeh R.W.
        Population trends in rates of percutaneous coronary interventions, 2010 to 2017.
        JAMA Cardiol. 2021; 6: 1219-1220
        • Cutlip D.E.
        • Chauhan M.S.
        • Baim D.S.
        • et al.
        Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.
        J Am Coll Cardiol. 2002; 40: 2082-2089
        • Piccolo R.
        • Stefanini G.G.
        • Franzone A.
        • et al.
        Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis.
        Circ Cardiovasc Interv. 2015; 8 (e002223)
        • Moussa I.D.
        • Mohananey D.
        • Saucedo J.
        • et al.
        Trends and outcomes of restenosis after coronary stent implantation in the United States.
        J Am Coll Cardiol. 2020; 76: 1521-1531
        • Suntharalingam M.
        • Laskey W.
        • Lansky A.J.
        • et al.
        Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry.
        Int J Radiat Oncol Biol Phys. 2002; 52: 1075-1082
        • Shlofmitz E.
        • Iantorno M.
        • Waksman R.
        Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review.
        Circ Cardiovasc Interv. 2019; 12e007023
      1. Hall E.J .GA. Radiobiology For the Radiologist, Eighth Edition. Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103.

      2. Dong W., Qiu B., Fan F. Adjuvant radiotherapy for keloids. Aesthetic Plast Surg.2021.

        • Kal H.B.
        • Veen R.E.
        Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Dose-effect relationship.
        Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft. 2005; 181 ([et al.]): 717-723
        • Waksman R.
        • Rodriguez J.C.
        • Robinson K.A.
        • et al.
        Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries.
        Circulation. 1997; 96: 1944-1952
        • Wiedermann J.G.
        • Marboe C.
        • Amols H.
        • et al.
        Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model.
        J Am Coll Cardiol. 1994; 23: 1491-1498
        • Verin V.
        • Popowski Y.
        • Urban P.
        • et al.
        Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model.
        Circulation. 1995; 92: 2284-2290
        • Ohri N.
        • Sharma S.
        • Kini A.
        • et al.
        Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents.
        Advances in Radiat Oncol. 2016; 1: 4-9
        • Varghese M.J.
        • Bhatheja S.
        • Baber U.
        • et al.
        Intravascular brachytherapy for the management of repeated multimetal-layered drug-eluting coronary stent restenosis.
        Circul Cardiovasc Intervent. 2018; 11e006832
        • Sigwart U.
        • Puel J.
        • Mirkovitch V.
        • et al.
        Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.
        The New Eng J Med. 1987; 316: 701-706
        • Serruys P.W.
        • de Jaegere P.
        • Kiemeneij F.
        • et al.
        A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
        The New Eng J Med. 1994; 331: 489-495
        • Fischman D.L.
        • Leon M.B.
        • Baim D.S.
        • et al.
        A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.
        The New Eng J Med. 1994; 331: 496-501
        • Farb A.
        • Sangiorgi G.
        • Carter A.J.
        • et al.
        Pathology of acute and chronic coronary stenting in humans.
        Circulation. 1999; 99: 44-52
        • Kim M.S.
        • Dean L.S.
        In-stent restenosis.
        Cardiovasc Ther. 2011; 29: 190-198
        • Teirstein P.S.
        • Massullo V.
        • Jani S.
        • et al.
        Catheter-based radiotherapy to inhibit restenosis after coronary stenting.
        The New Eng J Med. 1997; 336: 1697-1703
        • Waksman R.
        • White R.L.
        • Chan R.C.
        • et al.
        Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis.
        Circulation. 2000; 101: 2165-2171
        • Holmes D.R.
        • Teirstein P.
        • Satler L.
        • et al.
        Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
        JAMA. 2006; 295: 1264-1273
        • Stone G.W.
        • Ellis S.G.
        • O'Shaughnessy C.D.
        • et al.
        Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
        JAMA. 2006; 295: 1253-1263
        • Negi S.I.
        • Torguson R.
        • Gai J.
        • et al.
        Intracoronary brachytherapy for recurrent drug-eluting stent failure.
        JACC Cardiovasc Intervent. 2016; 9: 1259-1265
        • Waksman R.
        • Cheneau E.
        • Ajani A.E.
        • et al.
        Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies.
        Circulation. 2003; 107: 1744-1749
        • Leon M.B.
        • Teirstein P.S.
        • Moses J.W.
        • et al.
        Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting.
        The New Eng J Med. 2001; 344: 250-256
        • Waksman R.
        • Raizner A.E.
        • Yeung A.C.
        • et al.
        Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial.
        Lancet. 2002; 359: 551-557
        • Popma J.J.
        • Suntharalingam M.
        • Lansky A.J.
        • et al.
        Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis.
        Circulation. 2002; 106: 1090-1096
        • Serruys P.W.
        • Wijns W.
        • Sianos G.
        • et al.
        Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: beta-Radiation Investigation with Direct Stenting and Galileo in Europe (BRIDGE).
        J Am Coll Cardiol. 2004; 44: 528-537
        • Morice M.C.
        • Serruys P.W.
        • Sousa J.E.
        • et al.
        A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
        The New Eng J Med. 2002; 346: 1773-1780
        • Moses J.W.
        • Leon M.B.
        • Popma J.J.
        • et al.
        Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
        The New Eng J Med. 2003; 349: 1315-1323
        • Schampaert E.
        • Cohen E.A.
        • Schlüter M.
        • et al.
        The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).
        J Am Coll Cardiol. 2004; 43: 1110-1115
        • Schofer J.
        • Schlüter M.
        • Gershlick A.H.
        • et al.
        Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).
        Lancet. 2003; 362: 1093-1099
        • Colombo A.
        • Drzewiecki J.
        • Banning A.
        • et al.
        Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.
        Circulation. 2003; 108: 788-794
        • Stone G.W.
        • Ellis S.G.
        • Cox D.A.
        • et al.
        One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
        Circulation. 2004; 109: 1942-1947
        • Kastrati A.
        • Mehilli J.
        • von Beckerath N.
        • et al.
        Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
        JAMA. 2005; 293: 165-171
        • Holmes D.R.
        • Teirstein P.S.
        • Satler L.
        • et al.
        3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
        JACC Cardiovasc Intervent. 2008; 1: 439-448
        • Alli O.O.
        • Teirstein P.S.
        • Satler L.
        • et al.
        Five-year follow-up of the sirolimus-eluting stents vs vascular brachytherapy for bare metal In-Stent Restenosis (SISR) trial.
        Am Heart J. 2012; 163: 438-445
        • Megaly M.
        • Glogoza M.
        • Xenogiannis I.
        • et al.
        Coronary intravascular brachytherapy for recurrent coronary drug-eluting stent in-stent restenosis: a systematic review and meta-analysis.
        Cardiovasc Revasc Med. 2021; 23: 28-35
        • Räber L.
        • Jüni P.
        • Löffel L.
        • et al.
        Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation.
        J Am Coll Cardiol. 2010; 55: 1178-1188
        • Megaly M.
        • Glogoza M.
        • Xenogiannis I.
        • et al.
        Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis.
        Catheter Cardiovasc Interv. 2021; 97: 32-38
        • Bonello L.
        • Kaneshige K.
        • De Labriolle A.
        • et al.
        Vascular brachytherapy for patients with drug-eluting stent restenosis.
        J Interv Cardiol. 2008; 21: 528-534
        • Meraj P.M.
        • Patel K.
        • Patel A.
        • et al.
        Northwell intracoronary brachytherapy for the treatment of recurrent drug eluting stent in-stent restenosis (NITDI study group).
        Catheter Cardiovasc Interv. 2021; 97: 41-46
        • Mangione F.M.
        • Jatene T.
        • Badr Eslam R.
        • et al.
        Usefulness of intracoronary brachytherapy for patients with resistant drug-eluting stent restenosis.
        Am J Cardiol. 2017; 120: 369-373
        • Maluenda G.
        • Ben-Dor I.
        • Gaglia M.A.
        • et al.
        Clinical outcomes and treatment after drug-eluting stent failure: the absence of traditional risk factors for in-stent restenosis.
        Circul Cardiovasc Intervent. 2012; 5: 12-19
        • Yerasi C.
        • Chen Y.
        • Case B.C.
        • et al.
        Treatment of patients with recurrent coronary in-stent restenosis with failed intravascular brachytherapy.
        Am J Cardiol. 2021; 142: 44-51
        • Waksman R.
        • Bhargava B.
        • Mintz G.S.
        • et al.
        Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis.
        J Am Coll Cardiol. 2000; 36: 65-68
        • Vodovotz Y.
        • Waksman R.
        • Kim W.H.
        • et al.
        Effects of intracoronary radiation on thrombosis after balloon overstretch injury in the porcine model.
        Circulation. 1999; 100: 2527-2533
        • Michael T.T.
        • Papayannis A.C.
        • Banerjee S.
        • Brilakis E.S.
        Subintimal dissection/reentry strategies in coronary chronic total occlusion interventions.
        Circul Cardiovasc Intervent. 2012; 5: 729-738
        • Sharma R.
        • Kumar P.
        • Prashanth S.P.
        • Belagali Y.
        Dual antiplatelet therapy in coronary artery disease.
        Cardiol Ther. 2020; 9: 349-361
        • Feres F.
        • Munoz J.
        • Abizaid A.
        • et al.
        Angiographic and intravascular ultrasound findings of the late catch-up phenomenon after intracoronary beta-radiation for the treatment of in-stent restenosis.
        J Invasive Cardiol. 2005; 17: 473-477
        • Waksman R.
        • Ajani A.E.
        • White R.L.
        • et al.
        Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis.
        Circulation. 2004; 109: 340-344
        • Grise M.A.
        • Massullo V.
        • Jani S.
        • et al.
        Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial.
        Circulation. 2002; 105: 2737-2740
        • Chen Y.
        • Buchanan K.D.
        • Chan R.C.
        • et al.
        Combined vascular brachytherapy and stenting for the treatment of in-stent restenosis.
        Am J Cardiol. 2020; 125: 712-719
        • Siontis G.C.
        • Stefanini G.G.
        • Mavridis D.
        • et al.
        Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis.
        Lancet. 2015; 386: 655-664
        • Nakahama H.
        • Jankowski M.
        • Dixon S.R.
        • Abbas A.E.
        Long-term outcome of brachytherapy treatment for coronary in-stent restenosis: ten-year follow-up.
        Catheter Cardiovasc Interv. 2019; 93: E211-e216
        • Neumann F.J.
        • Sousa-Uva M.
        • Ahlsson A.
        • et al.
        2018 ESC/EACTS Guidelines on myocardial revascularization.
        Eur Heart J. 2019; 40: 87-165
        • Zhu Y.
        • Liu K.
        • Kong X.
        • et al.
        Comparison of drug-coated balloon angioplasty vs. drug-eluting stent implantation for drug-eluting stent restenosis in the routine clinical practice: a meta-analysis of randomized controlled trials.
        Frontiers in Cardiovasc Med. 2021; 8766088
        • Kearney K.E.
        • Wallner K.
        • Kim M.
        • et al.
        Intravascular coronary brachytherapy combined with a drug-coated balloon.
        Brachytherapy. 2021; 20: 1276-1281
        • Nikolakopoulos I.
        • Vemmou E.
        • Xenogiannis I.
        • Brilakis E.S.
        Combined use of intravascular lithotripsy and brachytherapy: a new approach for the treatment of recurrent coronary in-stent restenosis.
        Catheter Cardiovasc Interv. 2021; 97: 1402-1406
        • Ali Z.A.
        • Nef H.
        • Escaned J.
        • et al.
        Safety and effectiveness of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: the disrupt CAD II Study.
        Circul Cardiovasc Intervent. 2019; 12e008434
        • Sapontis J.
        • Salisbury A.C.
        • Yeh R.W.
        • et al.
        early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO registry (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures).
        JACC Cardiovascu Intervent. 2017; 10: 1523-1534
        • Mishra S.
        • Wolfram R.M.
        • Torguson R.
        • et al.
        Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosis.
        Am J Cardiol. 2006; 97: 1303-1307